{"DataElement":{"publicId":"2750637","version":"1","preferredName":"Lesion Histology Finding Type","preferredDefinition":"The subdivision that describes details of the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.","longName":"LES_HIST_FNG_TP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2503461","version":"1","preferredName":"Lesion Histology","preferredDefinition":"Information pertaining to an area of abnormal tissue change of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.","longName":"LES_HIST","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2465192","version":"1","preferredName":"Lesion","preferredDefinition":"(LEE-zhun) An area of abnormal tissue change.","longName":"C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-273D-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186387","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A9B0-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A0F42EF-2DC3-6762-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-02","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2750633","version":"1","preferredName":"Lesion Histology Finding Type","preferredDefinition":"The subdivision that describes details of the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.","longName":"LES_HIST_FNG_TP","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Erythroplakia","valueDescription":"Erythroplakia","ValueMeaning":{"publicId":"2573735","version":"1","preferredName":"Erythroplakia","longName":"2573735","preferredDefinition":"Erythroplakia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED14-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-03-23","modifiedBy":"MAESKEB","dateModified":"2005-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D9645E3-FF3F-2D86-E044-0003BA3F9857","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MAESKEB","dateModified":"2008-05-19","deletedIndicator":"No"},{"value":"Severe dysplasia","valueDescription":"Severe dysplasia","ValueMeaning":{"publicId":"2574091","version":"1","preferredName":"Severe dysplasia","longName":"2574091","preferredDefinition":"Severe dysplasia","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Dysplasia","conceptCode":"C8364","definition":"A morphologic finding indicating the presence of severe cellular atypia associated with severe architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE78-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D9645E3-FF4B-2D86-E044-0003BA3F9857","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MAESKEB","dateModified":"2008-05-19","deletedIndicator":"No"},{"value":"Moderate dysplasia","valueDescription":"Moderate dysplasia","ValueMeaning":{"publicId":"2567271","version":"1","preferredName":"Moderate dysplasia","longName":"2567271","preferredDefinition":"Moderate dysplasia","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate Dysplasia","conceptCode":"C8363","definition":"A morphologic finding indicating the presence of moderate cellular atypia associated with moderate architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D9645E3-FF57-2D86-E044-0003BA3F9857","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MAESKEB","dateModified":"2008-05-19","deletedIndicator":"No"},{"value":"Hyperplastic leukoplakia","valueDescription":"Hyperplastic leukoplakia","ValueMeaning":{"publicId":"2750634","version":"1","preferredName":"Hyperplastic leukoplakia","longName":"2750634","preferredDefinition":"Hyperplastic leukoplakia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9645E3-FF63-2D86-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D9645E3-FF7C-2D86-E044-0003BA3F9857","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MAESKEB","dateModified":"2008-05-19","deletedIndicator":"No"},{"value":"Mild dysplasia","valueDescription":"Mild dysplasia","ValueMeaning":{"publicId":"2574090","version":"1","preferredName":"Mild dysplasia","longName":"2574090","preferredDefinition":"Mild dysplasia","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild Dysplasia","conceptCode":"C8362","definition":"A morphologic finding indicating the presence of mild cellular atypia associated with mild architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE77-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D9645E3-FF88-2D86-E044-0003BA3F9857","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MAESKEB","dateModified":"2008-05-19","deletedIndicator":"No"},{"value":"Atypical cells","valueDescription":"Atypical cells","ValueMeaning":{"publicId":"2750635","version":"1","preferredName":"Atypical cells","longName":"2750635","preferredDefinition":"Atypical cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9645E3-FF94-2D86-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D9645E3-FFAD-2D86-E044-0003BA3F9857","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MAESKEB","dateModified":"2008-05-19","deletedIndicator":"No"},{"value":"Carcinoma","valueDescription":"Carcinoma","ValueMeaning":{"publicId":"2935533","version":"1","preferredName":"Carcinoma","longName":"2935533","preferredDefinition":"A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4BB-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71F88553-C4D4-17CC-E040-BB89AD43398B","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"ONEDATA","dateModified":"2009-08-25","deletedIndicator":"No"},{"value":"Carcinoma IN SITU","valueDescription":"Carcinoma In Situ","ValueMeaning":{"publicId":"2935534","version":"1","preferredName":"Carcinoma In Situ","longName":"2935534v1.00","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4DE-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":"Updated definition with current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71F88553-C4F7-17CC-E040-BB89AD43398B","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"ONEDATA","dateModified":"2009-08-25","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"2567281","version":"1","preferredName":"Normal","longName":"2567281","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3DE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71F88553-C501-17CC-E040-BB89AD43398B","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"ONEDATA","dateModified":"2009-08-25","deletedIndicator":"No"},{"value":"Low grade dysplasia","valueDescription":"Low Grade Dysplasia","ValueMeaning":{"publicId":"3028644","version":"1","preferredName":"Low Grade Dysplasia","longName":"3028644","preferredDefinition":"denoting slow growth; indolent.: A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.  Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dysplasia","conceptCode":"C4086","definition":"A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8255BEBE-C872-0FB8-E040-BB89AD4354E0","latestVersionIndicator":"Yes","beginDate":"2010-03-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8255BEBE-C88B-0FB8-E040-BB89AD4354E0","beginDate":"2010-03-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-21","modifiedBy":"ONEDATA","dateModified":"2010-03-21","deletedIndicator":"No"},{"value":"Squamous Metaplasia","valueDescription":"Squamous Metaplasia","ValueMeaning":{"publicId":"2965042","version":"1","preferredName":"Squamous Metaplasia","longName":"2965042","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Metaplasia","conceptCode":"C3237","definition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A244D8A-5283-31A8-E040-BB89AD436F56","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A244D8A-529C-31A8-E040-BB89AD436F56","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"ONEDATA","dateModified":"2009-12-07","deletedIndicator":"No"},{"value":"Reserve Cell Hyperplasia","valueDescription":"Reserve Cell Hyperplasia","ValueMeaning":{"publicId":"2965043","version":"1","preferredName":"Reserve Cell Hyperplasia","longName":"2965043","preferredDefinition":"The reserve cells proliferate to form two layers of reserve cell hyperplasia beneath the overlying layer of columnar epithelium, and occurs in Gynecologic and lung cancers.  The type of hyperplasia often evolves into squamous hyperplasia.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A244D8A-52A6-31A8-E040-BB89AD436F56","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A244D8A-52BF-31A8-E040-BB89AD436F56","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"ONEDATA","dateModified":"2009-12-07","deletedIndicator":"No"},{"value":"Inadequate Specimen","valueDescription":"Inadequate Sample","ValueMeaning":{"publicId":"2965044","version":"1","preferredName":"Inadequate Sample","longName":"2965044","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A244D8A-52CC-31A8-E040-BB89AD436F56","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A244D8A-52E5-31A8-E040-BB89AD436F56","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"ONEDATA","dateModified":"2009-12-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B72C-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Hyperplasia","valueDescription":"Hyperplasia","ValueMeaning":{"publicId":"2574092","version":"1","preferredName":"Hyperplasia","longName":"2574092","preferredDefinition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B736-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Abnormal","valueDescription":"Abnormal","ValueMeaning":{"publicId":"2570062","version":"1","preferredName":"Abnormal","longName":"2570062","preferredDefinition":"Deviating from the norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DEBB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"COOPERM","dateModified":"2008-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCE4EA-4A3F-BBE9-E040-BB89AD430980","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"Invasive adenocarcinoma","valueDescription":"Invasive Adenocarcinoma","ValueMeaning":{"publicId":"4117371","version":"1","preferredName":"Invasive Adenocarcinoma","longName":"4117371","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCE4EA-4A4C-BBE9-E040-BB89AD430980","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCE4EA-4A65-BBE9-E040-BB89AD430980","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"Hyperplastic Polyp","valueDescription":"Hyperplasia Polyp","ValueMeaning":{"publicId":"4117372","version":"1","preferredName":"Hyperplasia Polyp","longName":"4117372","preferredDefinition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: A usually exophytic mass attached to the underlying tissue by a broad base or a thin stalk.  Polyps can be neoplastic or non-neoplastic.  Neoplastic polyps usually represent proliferations of the epithelium, and are commonly seen in the gastrointestinal tract.  Polyps of the gastrointestinal tract are often called adenomas, are associated with dysplasia, and may eventually transform into carcinomas.  Non-neoplastic polyps may be inflammatory, degenerative, or the result of malformations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polyp","conceptCode":"C3340","definition":"A usually exophytic mass attached to the underlying tissue by a broad base or a thin stalk.  Polyps can be neoplastic or non-neoplastic.  Neoplastic polyps usually represent proliferations of the epithelium, and are commonly seen in the gastrointestinal tract.  Polyps of the gastrointestinal tract are often called adenomas, are associated with dysplasia, and may eventually transform into carcinomas.  Non-neoplastic polyps may be inflammatory, degenerative, or the result of malformations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCE4EA-4A72-BBE9-E040-BB89AD430980","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCE4EA-4A8D-BBE9-E040-BB89AD430980","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"Adenoma","valueDescription":"Adenoma","ValueMeaning":{"publicId":"2838898","version":"1","preferredName":"Adenoma","longName":"2838898","preferredDefinition":"A neoplasm arising from the glandular epithelium.  It may be encapsulated or non-encapsulated.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenoma","conceptCode":"C2855","definition":"A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62AB59ED-A488-4EBE-E040-BB89AD4348C8","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCE4EA-4A97-BBE9-E040-BB89AD430980","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"High Grade Dysplasia","valueDescription":null,"ValueMeaning":{"publicId":"6514327","version":"1","preferredName":"High Grade Dysplasia","longName":"6514327","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Dysplasia","conceptCode":"C156083","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB38-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4CA92E9-C2B2-0EA1-E053-731AD00AFACF","beginDate":"2023-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-15","modifiedBy":"MMADDINENI","dateModified":"2023-02-15","deletedIndicator":"No"},{"value":"Esophagitis","valueDescription":null,"ValueMeaning":{"publicId":"2746383","version":"1","preferredName":"Esophagitis","longName":"2746383","preferredDefinition":"Inflammation, acute or chronic, of the esophagus caused by bacteria, chemicals, or trauma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagitis","conceptCode":"C9224","definition":"An acute or chronic inflammatory process affecting the esophageal wall.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-724E-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4CA92E9-C2B3-0EA1-E053-731AD00AFACF","beginDate":"2023-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-15","modifiedBy":"MMADDINENI","dateModified":"2023-02-15","deletedIndicator":"No"},{"value":"Indefinite for dysplasia (IND)","valueDescription":null,"ValueMeaning":{"publicId":"12571831","version":"1","preferredName":"Indefinite Dysplasia","longName":"12571831v1.00","preferredDefinition":"An indication that there is an ambiguous morphological pattern in a tissue sample such that the presence or absence of dysplasia cannot be determined.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indefinite Dysplasia","conceptCode":"C164039","definition":"An indication that there is an ambiguous morphological pattern in a tissue sample such that the presence or absence of dysplasia cannot be determined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4CA92E9-C2B1-0EA1-E053-731AD00AFACF","latestVersionIndicator":"Yes","beginDate":"2023-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-15","modifiedBy":"MMADDINENI","dateModified":"2023-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4CA92E9-C2B4-0EA1-E053-731AD00AFACF","beginDate":"2023-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-15","modifiedBy":"MMADDINENI","dateModified":"2023-02-15","deletedIndicator":"No"},{"value":"Intestinal metaplasia","valueDescription":null,"ValueMeaning":{"publicId":"3250504","version":"1","preferredName":"Intestinal Metaplasia","longName":"3250504","preferredDefinition":"A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal Metaplasia","conceptCode":"C8360","definition":"A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C73C-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4CA92E9-C2B5-0EA1-E053-731AD00AFACF","beginDate":"2023-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-15","modifiedBy":"MMADDINENI","dateModified":"2023-02-15","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2831117","version":"1","preferredName":"Adenocarcinoma","longName":"2831117","preferredDefinition":"carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D06-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4CA92E9-C2B6-0EA1-E053-731AD00AFACF","beginDate":"2023-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-15","modifiedBy":"MMADDINENI","dateModified":"2023-02-15","deletedIndicator":"No"},{"value":"Tubular Adenoma","valueDescription":null,"ValueMeaning":{"publicId":"3247845","version":"1","preferredName":"Tubular Adenoma","longName":"3247845","preferredDefinition":"A usually polypoid neoplasm arising from the glandular epithelium. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. Representative examples include the tubular adenomas of the colon and rectum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubular Adenoma","conceptCode":"C4133","definition":"An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a tubular architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67A743F-5D8B-D6C3-E040-BB89AD436761","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF7B1C1-4912-131F-E063-731AD00A2CA9","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Tubulovillous Adenoma","valueDescription":null,"ValueMeaning":{"publicId":"3247843","version":"1","preferredName":"Tubulovillous Adenoma","longName":"3247843","preferredDefinition":"An epithelial neoplasm morphologically characterized by the presence of a villous and a tubular architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach in which the neoplastic epithelial cells show dysplastic features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubulovillous Adenoma","conceptCode":"C4143","definition":"An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a tubular and a villous architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67A743F-5D65-D6C3-E040-BB89AD436761","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF7B1C1-4913-131F-E063-731AD00A2CA9","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Villous Adenoma","valueDescription":null,"ValueMeaning":{"publicId":"3247842","version":"1","preferredName":"Villous Adenoma","longName":"3247842","preferredDefinition":"An epithelial neoplasm morphologically characterized by the presence of a villous architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach in which the neoplastic epithelial cells show dysplastic features. It may also arise in the urinary bladder, urethra, and vagina.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Villous Adenoma","conceptCode":"C7399","definition":"An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a villous architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67A743F-5D40-D6C3-E040-BB89AD436761","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF7B1C1-4914-131F-E063-731AD00A2CA9","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Hamartomas","valueDescription":null,"ValueMeaning":{"publicId":"3249799","version":"1","preferredName":"Hamartoma","longName":"3249799","preferredDefinition":"A benign and excessive tumor-like growth of mature cells and normal tissues which grow in a disorganized pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hamartoma","conceptCode":"C3075","definition":"A benign and excessive tumor-like growth of mature cells and normal tissues which grow in a disorganized pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DC37F6-D134-75B6-E040-BB89AD430517","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF7B1C1-4915-131F-E063-731AD00A2CA9","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Lymphoid Aggregates","valueDescription":null,"ValueMeaning":{"publicId":"11009271","version":"1","preferredName":"Lymphoid Aggregates Measurement","longName":"11009271v1.00","preferredDefinition":"The determination of th lymphoid aggregates in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoid Aggregates Measurement","conceptCode":"C187947","definition":"The determination of th lymphoid aggregates in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC1C9C-B1B9-6FBB-E053-731AD00A3EE4","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF7B1C1-4916-131F-E063-731AD00A2CA9","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Inflammatory Polyps","valueDescription":null,"ValueMeaning":{"publicId":"14651987","version":"1","preferredName":"Inflammatory Fibroid Polyp","longName":"14651987v1.00","preferredDefinition":"A benign, often polypoid, hypocellular fibroblastic neoplasm with a predilection for the stomach and ileum, containing a prominent inflammatory infiltrate, especially eosinophils. (WHO 2019)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Fibroid Polyp","conceptCode":"C172941","definition":"A benign, often polypoid, hypocellular fibroblastic neoplasm with a predilection for the stomach and ileum, containing a prominent inflammatory infiltrate, especially eosinophils. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF7B1C1-4911-131F-E063-731AD00A2CA9","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF7B1C1-4917-131F-E063-731AD00A2CA9","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2750632","version":"1","preferredName":"Lesion Histology Finding Type","preferredDefinition":"(LEE-zhun) An area of abnormal tissue change.:The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.:Type; a subdivision of a particular kind of thing.","longName":"C3824:C16681:C3367:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9645E3-FF19-2D86-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"ONEDATA","dateModified":"2008-05-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9645E3-FF2A-2D86-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MMADDINENI","dateModified":"2023-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"}]},{"publicId":"2931931","version":"1","longName":"Iloprost Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2931952","version":"1","longName":"Iloprost 12079","context":"SPOREs"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"},{"publicId":"4528056","version":"1","longName":"NWU2013-02-01","context":"DCP"}]}],"AlternateNames":[{"name":"SPOREs","type":"USED_BY","context":"SPOREs"},{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histology Details","type":"Preferred Question Text","description":"Histology Details","url":null,"context":"DCP"},{"name":"Histology","type":"Alternate Question Text","description":"Histology","url":null,"context":"DCP"},{"name":"Histologic Type","type":"Alternate Question Text","description":"Histologic Type","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9645E3-FFBB-2D86-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-05-19","modifiedBy":"MMADDINENI","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":"02/16/2023-Added PVs-CADSR0002028(DCP)-MM","unresolvedIssues":null,"deletedIndicator":"No"}}